Uterus Cancer

The most common type of uterine cancer is endometrial carcinoma, which accounts for the vast majority of cases. Less common forms include uterine sarcomas, which arise from the muscle or connective tissue of the uterus and tend to behave more aggressively. These subtypes differ in prognosis and treatment approach, making accurate classification essential.

Several risk factors are associated with uterine cancer development. These include prolonged exposure to estrogen without progesterone balance, obesity, diabetes, polycystic ovary syndrome, early menstruation, late menopause, and use of certain hormone therapies. A family history of colorectal or endometrial cancer, particularly in Lynch syndrome, also significantly increases risk.

The most common early symptom is abnormal uterine bleeding, especially postmenopausal bleeding or unusually heavy or irregular menstrual bleeding in premenopausal individuals. Other symptoms may include pelvic pain, pain during intercourse, or unexplained vaginal discharge. Because early symptoms are often noticeable, uterine cancer is frequently diagnosed at an earlier stage compared to many other cancers.

Diagnosis typically involves a pelvic examination, transvaginal ultrasound, and an endometrial biopsy to collect tissue for pathological analysis. In some cases, dilation and curettage (D&C) or hysteroscopy is performed for more comprehensive sampling. Imaging studies such as MRI or CT scans may be used to assess the extent of disease spread.

Treatment depends on the stage and type of uterine cancer but most commonly includes surgery, particularly hysterectomy (removal of the uterus), often combined with removal of the fallopian tubes and ovaries. Depending on risk factors and disease progression, radiation therapy, chemotherapy, hormone therapy, or targeted treatments may also be recommended.

Advances in minimally invasive surgical techniques, such as laparoscopic or robotic-assisted hysterectomy, have improved recovery times and reduced complications for many patients. Personalized medicine approaches, including molecular tumor profiling, are increasingly guiding treatment decisions to improve outcomes and reduce overtreatment.

Living with uterine cancer can involve both physical recovery and emotional adjustment, particularly for those undergoing reproductive organ removal or systemic therapy. Supportive care, including pain management, counseling, fertility preservation discussions when appropriate, and survivorship programs, plays a critical role in overall wellbeing. With early detection and appropriate treatment, many individuals achieve excellent long-term outcomes.

Publisher - Xspurts.com

Language - English

Perfect Bound

Contributors

By author

Wyatt U. Sinclair

Published Date - 2026-05-26

ISBN - 9781776830237

Dimensions - 19.7 x 13.2 x 1.1 cm

Page Count - 200